Adverse event development in clinical oncology trials – Authors' reply

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)e264-e265
JournalThe Lancet Oncology
Volume17
Issue number7
DOIs
StatePublished - Jul 1 2016

ASJC Scopus subject areas

  • Oncology

Cite this